Moderna Inc Newsfeed

330.0
USD
+20.67%
a day ago
Negative (-0.19)
News Sentiment
649
Knowledge Entities
144
News (1 week)

Coronavirus vaccine makers such as Moderna (MRNA), BioNTech (BNTX) and Pfizer (PFE) were big winners. Both Moderna stock and BioNTech could be deemed early entries. But investors might want to see more strength from Moderna and a post-gap up consolidation from BNTX stock. Coronavirus Vaccine Stocks Pfizer and partner BioNTech, along with rival mRNA coronavirus vaccine maker Moderna, jumped on the Omicron Covid variant, also called Nu Covid. MRNA stock gapped above its 50-day line, breaking a trend line with a 21% gain.

Knowledge Entities:
Day
Moderna
Coronavirus
Pfizer
IBD
BioNTech
Dow Jones Futures
Covid variant
investors
start
Moderna Inc (MRNA)
Nov 27, 2021
investors.com
TickerTick API

New Covid variant: It is one of three strategies the company is working to combat the new corona variant, including a higher dose of its existing vaccine, Moderna said

Knowledge Entities:
Moderna
Moderna said
develop
working
address
US pharmaceutical company
Moderna says
headline
Enter
Moderna Inc (MRNA)
Nov 27, 2021
livemint.com
TickerTick API

CEO of Moderna Inc (30-Year Financial, Insider Trades) Stephane Bancel (insider trades) sold 9,000 shares of MRNA on 11/24/2021 at an average price of $273.01 a share. The total sale was $2.5 million. For the complete insider trading history of MRNA, click here

Knowledge Entities:
Insider Trades
Moderna Inc
shares
Stephane Bancel
Year Financial
FINANCIAL
click
Moderna Inc (MRNA)
Nov 27, 2021
gurufocus.com
TickerTick API

Data is expected in the coming weeks, the statement noted

Knowledge Entities:
SARS-CoV-2
Expected
Moderna
vaccine
COV
Moderna Inc (MRNA)
Nov 26, 2021
Tass
IEX API

Story continues below advertisement Moderna Inc said in a statement it is working to advance a booster candidate tailored to the new variant and has also been testing a higher dose of its existing booster and to study other booster candidates designed to protect against multiple variants. “A booster dose of an authorized vaccine represents the only currently available strategy for boosting waning immunity,” Moderna said in the statement. Moderna gained 20.6 per cent to close at $329.63. Send this page to someone via email BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked. Pfizer and BioNTech said that if necessary they expect to be able to ship a new vaccine tailored to the emerging variant in approximately 100 days.

Knowledge Entities:
BioNTech
vaccine
Moderna
Pfizer
Expect
Africa
BioNTech said
PROTECT
Omicron
Booster dose
Moderna Inc (MRNA)
Nov 26, 2021
globalnews.ca
TickerTick API

The US pharmaceutical company Moderna said Friday it will develop a booster shot against the new Omicron variant of the coronavirus.

Knowledge Entities:
Moderna
Moderna said
develop
Omicron variant
US pharmaceutical company
address
Moderna Says
headline
working
Moderna Inc (MRNA)
Nov 26, 2021
ndtv.com
TickerTick API

Moderna Inc. undefined said Friday it will "rapidly advance" an omicron-specific COVID-19 booster vaccine candidate and continue to work on booster...

Knowledge Entities:
Moderna
specific COVID
COVID-19
Moderna Inc
Shares
European Union
Booster
Pfizer Inc.
Pfizer
Moderna Inc (MRNA)
Nov 26, 2021
Market Watch
TickerTick API

Moderna Inc. revealed on Friday that it "will rapidly advance" a booster candidate of its coronavirus vaccine that would specifically fight the Omicron variant of the disease. The Massachus

Knowledge Entities:
Moderna
Moderna Inc
Disease
Moderna Inc (MRNA)
Nov 26, 2021
Breaking the News 24/7
IEX API

Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant

Knowledge Entities:
Moderna
Booster
vaccine
COV
SARS-CoV-2
test
SARS-CoV-2 Variant
Omicron variant
B.1.1.529
Delta variant
Moderna Inc (MRNA)
Nov 26, 2021
Business Wire
TickerTick API

Investors sought shelter in the COVID-19 vaccine maker's shares.

Knowledge Entities:
Moderna
shares
Moderna Inc (MRNA)
Nov 26, 2021
The Motley Fool
Stock News API

The Dow Jones suffered its worst day of 2021 amid new Covid fears. Moderna stock popped. A Warren Buffett stock rebounded higher.

Knowledge Entities:
Chinese e
Moderna
Warren Buffett
Dow Jones
Covid
European Commission
Booking Holdings
global markets
Swiss franc
Snowflake
Marriott International
Moderna Inc (MRNA)
Nov 26, 2021
investors.com
TickerTick API

CNBC's Meg Tirell (pictured) reports that Pfizer and Moderna both are taking action to potentially update their COVID-19 vaccines if need be in wake of the newly discovered South African virus strain The new strain has over 30 mutations, it what has been described as a 'constellation' by some 'Moderna and BioNTech and Pfizer tell us that they are already looking at this very closely and have told us they can update the vaccines very quickly if they need to' CNBC's Meg Tirell said on TechCheck Friday. More than 108 million Americans have been fully vaccinated by the Pfizer-BioNTech vaccine, and 71.5 million by the Moderna shot according to data published Wednesday by the U.S. Centers for Disease Control and Prevention (CDC). Pfizer and Moderna both report that they can get out updated vaccines in the coming months if needed. Pictured: vials of the Pfizer and Moderna COVID-19 vaccines Because of the new nature of the variant, not much is known about it yet. Pfizer, its vaccine partner BioNTech and Moderna, who are responsible for producing the two most common vaccines in the U.S., have all said they can quickly update the vaccines to provide protection against the emerging variant, if necessary.

Knowledge Entities:
vaccines
Moderna
Pfizer
BioNTech
U.S.
reports
Meg Tirell
CNBC
African
Pfizer/BioNTech
Moderna Inc (MRNA)
Nov 26, 2021
dailymail.co.uk
TickerTick API

Search Result News Sentiment:

Related Stocks

Start With StockBrain Today, Fetch Data in Minutes
News Analytics and Sentiment Data for 8000 Companies at your fingertips.
Create Free Account

Start For Free - No Upfront Commitment

We offer a Free Tier that will remain free forever. Start Now!

Need A Specific Data Set For Your Project?

Steer Our API Development In The Right Direction. Tell us which data you need!
© StockBrain.io